A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience
Issue link: http://innovationscns.epubxp.com/i/499434
President Steven Romano, MD, Pfizer, Inc. President Elect Stephen Marder, MD, Semel Institute for Neuroscience, UCLA Scientific Program Chair Thomas Laughren, MD, Laughren Psychopharm Consulting, LLC Treasurer Ramy Mahmoud, MD, MPH, Optinose Secretary Carla Canuso, MD, Janssen Pharmaceutical Companies Past President Richard Keefe, PhD, Duke University Medical Center Members at Large Karl Broich, MD, BfArM Phillip Chappell, MD, MBA, Pfizer, Inc. Michael Davidson, MD, Tel Aviv University, Sackley School of Medicine Philip Harvey, PhD, University of Miami Miller School of Medicine Ginger Haynes, PhD, Eli Lilly and Company Jonathan Rabinowitz, PhD, Bar Ilan University Nina R. Schooler, PhD, SUNY Downstate Medical Center Dawn Velligan, PhD, University of Texas Health Science Center, San Antonio Executive Director Carlotta McKee, ISCTM PO Box 128061 Nashville, Tennessee 37212 USA Tel: +1 615 383 7688 Fax: +1 615 296 0454 E-mail: firstname.lastname@example.org Visit isctm.org for more information. 2015–2016 EXECUTIVE COMMITTEE E DITOR Amir H. Kalali, MD Vice President, Global Therapeutic Group Leader C NS, Quintiles Inc.; Professor of Psychiatry, U niversity of California, San Diego, California PRESIDENT/GROUP PUBLISHER R obert L. Dougherty M atrix Medical Communications W est Chester, Pennsylvania P ARTNER P atrick D. Scullin Matrix Medical Communications West Chester Pennsylvania V ICE PRESIDENT, BUSINESS DEVELOPMENT J oseph J. Morris Matrix Medical Communications West Chester, Pennsylvania V ICE PRESIDENT, EXECUTIVE EDITOR E lizabeth A. Klumpp Matrix Medical Communications W est Chester, Pennsylvania ASSOCIATE EDITOR K imberly B. Chesky M atrix Medical Communications West Chester, Pennsylvania ASSISTANT EDITOR Angela M. Saba Matrix Medical Communications West Chester, Pennsylvania EDITORIAL CORRESPONDENCE should be directed to Elizabeth Klumpp, Executive Editor, Matrix Medical Communications, E-mail: email@example.com; Phone: (484) 266- 0702 ADVERTISING QUERIES should be directed to Robert Dougherty, President/Group Publisher, Matrix Medical Communications; E-mail: firstname.lastname@example.org; Phone: (484) 266-0702 INDEXING— Innovations in Clinical Neuroscience is indexed with PubMed Central, PsycINFO, CINAHL ® Plus with Full Text, Scopus, and Embase. Copyright © 2015 Matrix Medical Communications. All rights reserved. Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Matrix Medical Communications, the editorial staff, or any member of the editorial advisory board. Matrix Medical Communications is not responsible for accuracy of dosages given in the articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Matrix Medical Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements. Innovations in Clinical Neuroscience, ISSN 2158- 8333 (Print) and ISSN 2158-8341(Online), is published 6 times yearly by Matrix Medical Communications. Visit www.innovationscns.com for subscription or submission information.